The same in other media
COMMENTARY: How COVID-19 vaccines are being tested in clinical trials
Reading now: 980
President Donald Trump announced that the U.S. will have a vaccine for COVID-19 “before the end of the year and maybe even before Nov.
1.”As an election looms in the United States, the declaration fuelled worry that a COVID-19 vaccine may be approved before scientific vetting is complete.In the United States, review and licensure of vaccines is the responsibility of the Food and Drug Administration (FDA).
But the agency’s handling of emergency use authorizations for two anti-malaria drugs and convalescent blood plasma for the treatment of COVID-19 have led to claims it has become politicized.Such is the worry about the impartiality of the FDA that pharmaceutical companies drew a line in the sand and pledged publicly only to submit a vaccine.
Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|
